Tower Research Capital (TRC)’s Azora Therapeutics AZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.13K Buy
1,777
+358
+25% +$1.54K ﹤0.01% 4492
2026
Q2
$3.63K Buy
1,419
+63
+5% +$125 ﹤0.01% 4501
2026
Q1
$2.43K Buy
1,356
+1,302
+2,411% +$4.58K ﹤0.01% 4481
2025
Q4
$295 Sell
54
-1
-2% -$8 ﹤0.01% 4949
2025
Q3
$484 Sell
55
-2
-4% -$19 ﹤0.01% 5002
2025
Q2
$429 Hold
57
– – ﹤0.01% 5027
2025
Q1
$905 Buy
57
+31
+119% +$640 ﹤0.01% 4806
2024
Q4
$644 Sell
26
-132
-84% -$3.44K ﹤0.01% 5214
2024
Q3
$3.94K Sell
158
-67
-30% -$1.75K ﹤0.01% 4732
2024
Q2
$6.48K Buy
225
+40
+22% +$1.51K ﹤0.01% 4575
2024
Q1
$6.15K Buy
185
+16
+9% +$599 ﹤0.01% 4425
2023
Q4
$7.88K Buy
+169
New +$9.26K ﹤0.01% 4569
2022
Q3
– Sell
-11
Closed -$9K – 6016
2022
Q2
$9K Buy
11
+3
+38% +$2.72K ﹤0.01% 4533
2022
Q1
$11K Buy
+8
New +$11K ﹤0.01% 4137
2021
Q4
– Hold
0
– – – 6094
2021
Q3
– Sell
-1
Closed -$2.09K – 5722
2021
Q2
$1K Sell
1
-1
-50% -$1.52K ﹤0.01% 5162
2021
Q1
$3K Sell
2
-1
-33% -$1.51K ﹤0.01% 4874
2020
Q4
$3K Sell
3
-1
-25% -$1.18K ﹤0.01% 4774
2020
Q3
$5K Buy
+4
New +$3.73K ﹤0.01% 4336
2018
Q4
– Sell
-1
Closed -$2K – 3779
2018
Q3
$2K Buy
+1
New +$2.08K ﹤0.01% 3395

Other funds holding AZR

Tower Research Capital (TRC)'s AZR Position: Q3 2026 in Review

Tower Research Capital (TRC) increased its Azora Therapeutics (AZR) stake by 25% in Q3 2026, buying an estimated $1.54K and bringing the position to 1,777 shares worth $7.13K. The position accounts for ﹤0.01% of the portfolio, ranked #4492.

Tower Research Capital (TRC) first reported a position in AZR in Q3 2018 and has held it in 19 quarters since. The position peaked at $11K in Q1 2022. 22 funds tracked by Wall St. Rank hold AZR as of Q3 2026.

  • Tower Research Capital (TRC) held 1,777 shares of Azora Therapeutics worth $7.13K as of Q3 2026.
  • Tower Research Capital (TRC) bought 358 Azora Therapeutics shares in Q3 2026, an estimated $1.54K.
  • Azora Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4492 holding.
  • Tower Research Capital (TRC) first reported a position in Azora Therapeutics in Q3 2018 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s Azora Therapeutics position peaked at $11K in Q1 2022.
  • 22 funds tracked by Wall St. Rank held Azora Therapeutics as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.